175 related articles for article (PubMed ID: 11333350)
1. One-year inhibition of tumor necrosis factor-alpha: a major success or a larger puzzle?
Graninger WB; Smolen JS
Curr Opin Rheumatol; 2001 May; 13(3):209-13. PubMed ID: 11333350
[TBL] [Abstract][Full Text] [Related]
2. New indications for treatment of chronic inflammation by TNF-alpha blockade.
Reimold AM
Am J Med Sci; 2003 Feb; 325(2):75-92. PubMed ID: 12589232
[TBL] [Abstract][Full Text] [Related]
3. [How I treat...rheumatoid arthritis. The arrival of a new therapeutic era: anti-tumor necrosis factor alpha antibodies].
Kaiser MJ; Malaise MG
Rev Med Liege; 2002 Aug; 57(8):486-92. PubMed ID: 12405019
[TBL] [Abstract][Full Text] [Related]
4. Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
Ciechomska M; Bonek K; Merdas M; Zarecki P; Swierkot J; Gluszko P; Bogunia-Kubik K; Maslinski W
Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):389-397. PubMed ID: 29744553
[TBL] [Abstract][Full Text] [Related]
5. The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study.
Heiberg MS; Nordvåg BY; Mikkelsen K; Rødevand E; Kaufmann C; Mowinckel P; Kvien TK
Arthritis Rheum; 2005 Aug; 52(8):2506-12. PubMed ID: 16052584
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis.
Paleolog E
Expert Opin Investig Drugs; 2003 Jul; 12(7):1087-95. PubMed ID: 12831345
[TBL] [Abstract][Full Text] [Related]
7. Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Voulgari PV
Expert Rev Clin Immunol; 2010 Sep; 6(5):721-33. PubMed ID: 20828280
[TBL] [Abstract][Full Text] [Related]
8. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
[TBL] [Abstract][Full Text] [Related]
9. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
Lanfant-Weybel K; Lequerré T; Vittecoq O
Presse Med; 2009 May; 38(5):774-87. PubMed ID: 19327945
[TBL] [Abstract][Full Text] [Related]
10. Golimumab, the newest TNF-α blocker, comes of age.
Papagoras C; Voulgari PV; Drosos AA
Clin Exp Rheumatol; 2015; 33(4):570-7. PubMed ID: 25602858
[TBL] [Abstract][Full Text] [Related]
11. TNF inhibitors in the treatment of arthritis.
Lorenz HM
Curr Opin Investig Drugs; 2000 Oct; 1(2):188-93. PubMed ID: 11249572
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha blockade in the treatment of rheumatoid arthritis.
Keystone EC
Rheum Dis Clin North Am; 2001 May; 27(2):427-43. PubMed ID: 11396102
[TBL] [Abstract][Full Text] [Related]
13. Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.
Gengenbacher M; Sebald HJ; Villiger PM; Hofstetter W; Seitz M
Ann Rheum Dis; 2008 May; 67(5):620-4. PubMed ID: 17720725
[TBL] [Abstract][Full Text] [Related]
14. TNF-blocking therapy in rheumatoid arthritis and ankylosing spondylitis: why is cost-effectiveness a major issue?
Merkesdal S; Zeidler H
Curr Rheumatol Rep; 2005 Aug; 7(4):254-8. PubMed ID: 16045826
[No Abstract] [Full Text] [Related]
15. How does infliximab work in rheumatoid arthritis?
Maini RN; Feldmann M
Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S22-8. PubMed ID: 12110154
[TBL] [Abstract][Full Text] [Related]
16. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
Segal B; Rhodus NL; Patel K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):778-87. PubMed ID: 18930662
[TBL] [Abstract][Full Text] [Related]
18. Golimumab: A novel anti-TNF-alpha human monoclonal antibody for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Campas-Moya C
Drugs Today (Barc); 2010 Jan; 46(1):13-22. PubMed ID: 20200692
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rheumatoid arthritis by TNF-blocking agents.
Graninger W; Smolen J
Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849
[TBL] [Abstract][Full Text] [Related]
20. Secukinumab for rheumatology: development and its potential place in therapy.
Koenders MI; van den Berg WB
Drug Des Devel Ther; 2016; 10():2069-80. PubMed ID: 27445458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
